Joe Nadglowski President & CEO, Obesity Action Coalition #ObesityCare #Medicare #GLP1 #HealthPolicy #OAC #OCAN To view or add a comment, sign in Folks with Medicare who are taking a GLP-1 drug should be aware of this new and important cost-saving program, which begins July 1, 2026
mTOR signalling and cellular metabolism are mutual determinants in cancer
Sufficient amounts of creatine are therefore important to prevent energy depletion
realistic expectations range from 2030% weight loss over 612 months, with improved body composition
Tirzepatide pros Effective for weight loss : Tirzepatide has shown significant weight loss results, with some patients losing over 20% of their body weight, especially in people with obesity
It treats and does not worsen insulin resistance, just like semaglutides treat diabetes